Immunogenicity and Safety of the 9-Valent Human Papillomavirus Vaccine in Solid Organ Transplant Recipients and Adults Infected With Human Immunodeficiency Virus (HIV).

Lise BoeyAns CurinckxMathieu RoelantsInge DerdelinckxEric Van WijngaerdenPaul De MunterRobin VosDirk KuypersJohan Van CleemputCorinne Vandermeulen

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)

Immunogenicity of the 9vHPV vaccine is high in persons living with HIV but suboptimal in SOT recipients. The vaccine is safe and well tolerated in both groups.

Keyphrases

human immunodeficiency virus
antiretroviral therapy
hepatitis c virus
hiv infected
hiv positive
hiv aids
hiv testing